PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,059,000 | +1486.4% | 447,963 | +528.9% | 0.04% | +1266.7% |
| Q1 2020 | $508,000 | -64.5% | 71,230 | +35.3% | 0.00% | -40.0% |
| Q2 2019 | $1,429,000 | -60.5% | 52,653 | -49.5% | 0.01% | -64.3% |
| Q1 2019 | $3,615,000 | +368.3% | 104,190 | +163.5% | 0.01% | +366.7% |
| Q4 2018 | $772,000 | +38.8% | 39,536 | +89.2% | 0.00% | +50.0% |
| Q3 2018 | $556,000 | -82.8% | 20,891 | -75.5% | 0.00% | -84.6% |
| Q2 2018 | $3,224,000 | – | 85,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |